EUVIMEDEUVIMED entdecken
Crossref

Feasibility and safety of direct percutaneous embolization of lymphopseudoaneurysm for postoperative lymphatic leakage

Mizuki Ozawa iD, Miyuki Sone, Shunsuke Sugawara, Chihiro Itou, Shintaro Kimura, Yasuaki Arai, Masahiko Kusumoto

Journal of Medical Imaging and Radiation Oncology · 2024

DOI: 10.1111/1754-9485.13666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2024. Verfasst von Mizuki Ozawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Feasibility Studies, Postoperative Complications. Die Arbeit nennt 16 Literaturangaben. Gefördert von: National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment strategy for refractory postoperative lymphatic leakage is controversial. While the utility of direct percutaneous embolization of lymphopseudoaneurysm has been investigated, only a few reports on this topic exist. The aim of this study was to evaluate the technical and clinical feasibility and safety of direct percutaneous embolization of lymphopseudoaneurysm for refractory postoperative lymphatic leakage. This case series included six consecutive patients who underwent direct percutaneous embolization of lymphopseudoaneurysm for refractory postoperative lymphatic leakage. Technical success (successful percutaneous approach and injection of NBCA glue to the lymphopseudoaneurysm), clinical success (unnecessity of percutaneous drainage tube of the lymphatic leakage), treatment duration (the duration from the treatment to the achievement of clinical success) and procedure‐related complications were mainly evaluated. Direct percutaneous embolization of the lymphopseudoaneurysm using NBCA glue was successfully performed in all cases. Clinical success was achieved in five of the six cases (83%). The mean treatment period was 9 days for the cases with clinical success. No major complications occurred postoperatively. In conclusion, direct percutaneous embolization of lymphopseudoaneurysm may become a feasible and safe treatment option for cases of refractory postoperative lymphatic leakage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolization, TherapeuticFeasibility StudiesPostoperative ComplicationsHumansFemaleMaleMiddle AgedTreatment OutcomeAgedAdultEnbucrilateLymphatic Diseases

Stichwörter der Autor:innen

embolizationleaklymphaticlymphopseudoaneurysmpercutaneous

Substanzen

Enbucrilate

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.

ORCID-Profile: Mizuki Ozawa

Förderung

  • National Cancer Center

Zitieren

APA

Ozawa, M., Sone, M., Sugawara, S., Itou, C., Kimura, S., Arai, Y., & Kusumoto, M. (2024). Feasibility and safety of direct percutaneous embolization of lymphopseudoaneurysm for postoperative lymphatic leakage. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13666

Vancouver

Ozawa M, Sone M, Sugawara S, Itou C, Kimura S, Arai Y, et al. Feasibility and safety of direct percutaneous embolization of lymphopseudoaneurysm for postoperative lymphatic leakage. Journal of Medical Imaging and Radiation Oncology. 2024. doi:10.1111/1754-9485.13666

BibTeX
@article{Ozawa2024,
  author = {Ozawa, Mizuki and Sone, Miyuki and Sugawara, Shunsuke and Itou, Chihiro and Kimura, Shintaro and Arai, Yasuaki and Kusumoto, Masahiko},
  title = {Feasibility and safety of direct percutaneous embolization of lymphopseudoaneurysm for postoperative lymphatic leakage},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2024},
  doi = {10.1111/1754-9485.13666}
}
Kostenlos starten →